✦ LIBER ✦
123 Anti-tumor activity of CXR1002, a novel anti-cancer clinical phase compound that induces ER stress and inhibits PIM kinases: Human tumor xenograft efficacy and in vitro mode of action
✍ Scribed by A. Barnett; S. Ding; C. Murray; M. Chamberlain; S. Plummer; T.R.J. Evans; I. MacPherson; D. Bissett; C.R. Elcombe; C.R. Wolf
- Book ID
- 119602805
- Publisher
- Elsevier Science
- Year
- 2010
- Tongue
- English
- Weight
- 62 KB
- Volume
- 8
- Category
- Article
- ISSN
- 1359-6349
No coin nor oath required. For personal study only.